Search

Your search keyword '"John, E.M."' showing total 331 results

Search Constraints

Start Over You searched for: Author "John, E.M." Remove constraint Author: "John, E.M."
331 results on '"John, E.M."'

Search Results

1. Impairment in work and activities of daily life in patients with psoriasis:results of the prospective BioCAPTURE registry

2. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort

4. Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis

6. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.

7. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort

8. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

9. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

11. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

12. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

13. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

14. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

15. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

16. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

17. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

18. Genetic insights into biological mechanisms governing human ovarian ageing.

19. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

20. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

21. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

22. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

23. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

24. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

25. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor.

26. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

27. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.

28. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

29. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

30. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

31. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

32. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

33. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

34. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

35. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

36. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

37. The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor

38. Two truncating variants in FANCC and breast cancer risk.

39. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Results from the BRCA1 and BRCA2 cohort consortium.

40. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

41. Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation Results.

42. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.

43. Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort.

44. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

45. Recreational physical activity is associated with reduced breast cancer risk in adult women at high risk for breast cancer: A cohort study of women selected for familial and genetic risk.

46. Erratum: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4).

47. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

48. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

49. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

50. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

Catalog

Books, media, physical & digital resources